trending Market Intelligence /marketintelligence/en/news-insights/trending/DR4oyLkJE1w4BeZqzIG0FQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Biotechnology company Inscripta raises $125M in series D round

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery


Biotechnology company Inscripta raises $125M in series D round

Inscripta Inc. raised $125 million in its series D funding round, which was led by Paladin Capital Group.

New investors JS Capital Management LLC and Oak HC/FT Partners LLC participated in the round, alongside existing investors.

Inscripta has now raised a total of $259.5 million.

Inscripta is a Boulder, Colo.-based biotechnology company that is developing a benchtop platform for genome-scale engineering.